n this trial, 13 patients were considered evaluable for response. Of these, one with a hormone-refractory breast cancer metastatic to the adrenal gland and bone had a complete response lasting 11 months. A similar patient had a partial response lasting 13.5 months. Four had stable disease: of these, one with thyroid cancer metastatic to the lung had 34.1 months stability, a non-small cell lung cancer patient was stable for 5.1 months, a patient with pancreatic cancer metastatic to liver was stabilized for 41 months and a patient with leiomyosarcoma remained stable for 4.0 months.
The authors concluded that "cancer-related frequencies appear to be tumor-specific and treatment with tumor-specific frequencies is feasible, well tolerated and may have biological efficacy in patients with advanced cancer."
The same authors had previously shown that administration of a low level electromagnetic field (at a frequency of 42.7 Hz) by means of a battery-powered portable device could change the brain waves of healthy volunteers and is associated with the relaxation effect. The device has been used to induce sleep in insomniacs.
The U.S. is seeing a late summer surge in COVID-19 cases, tracking from the Centers for...
The US’s top public health agency was plunged into chaos on Wednesday after the Trump administration...
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last...
